Top

Neurological Sciences

Published in:

01-10-2021 | Migraine | Original Article

Headache Gauge: a real-life calendar-based tool for headache monitoring

Authors: Raquel Gil-Gouveia, Inês Brás Marques, Elsa Paixão Parreira, Isabel Pavão Martins, António Gouveia Oliveira

Published in: Neurological Sciences | Issue 10/2021

Abstract

Background

This study aimed to validate a semi-quantitative composite score tool, “Headache Gauge” (HG), to monitor the treatment effect in primary headaches in everyday clinic practice, adjustable to any chosen timeframe.

Method

A cohort validation study of HG was performed in primary headache patients, recovering their clinical data and patient-related outcome measures (PROMs) for headache (HIT-6, MIDAS, HURT), work impact (WPAIQ), quality-of-life (SF-12), and mood (STAI, ZUNG). HG score distribution, its relation to clinical variables, its internal consistency, and its convergent validity were determined.

Results

HG was plotted in 233 patients: 90.1% females, age average 37 years, 86% with migraine, 27% with chronic headaches, and 28% with medication overuse. HG ranged from 0.21 to 58.3 in this sample, higher in chronic headaches (HG 16) and medication overuse (HG 15). HG presented good concurrent validity, significantly correlating with HIT-6 (p < 0.0001), SF-12 (p = 0.001), WPAIQ (p < 0.0001), MIDAS (p < 0.0001), and HURT (p < 0.0001). Good sensitivity to change (p < 0.001) and moderate test-retest reliability (p = 0.001) were calculated after reassessment of 147 patients (63.1% of the initial sample).

Conclusions

Headache Gauge is a clinical data-based outcome measure that conceptually translates the percentage of lost time to headache in any given timeframe. It relates to headache impact, therefore bearing the potential to be relevant in real-life clinical monitoring.

Brandes JL (2008) The migraine cycle: patient burden of migraine during and between migraine attacks. Headache 48:430–441. https://doi.org/10.1111/j.1526-4610.2007.01004.xCrossRefPubMed

Blau JN (1982) Resolution of migraine attacks: sleep and the recovery phase. J Neurol Neurosurg Psychiatry 45:223–226. https://doi.org/10.1136/jnnp.45.3.223CrossRefPubMedPubMedCentral

Leonardi M, Raggi A (2019) A narrative review on the burden of migraine: when the burden is the impact on people’s life. J Headache Pain 20:41. https://doi.org/10.1186/s10194-019-0993-0CrossRefPubMedPubMedCentral

Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646–657. https://doi.org/10.1046/j.1526-4610.2001.041007646.xCrossRefPubMed

Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Barré J, Andrée C (2014) The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain 15:1–11. https://doi.org/10.1186/1129-2377-15-31CrossRef

Bloudek LM, Stokes M, Buse DC, Wilcox TK, Lipton RB, Goadsby PJ, Varon SF, Blumenfeld AM, Katsarava Z, Pascual J, Lanteri-Minet M, Cortelli P, Martelletti P (2012) Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain 13:361–378. https://doi.org/10.1007/s10194-012-0460-7CrossRefPubMedPubMedCentral

Gil-Gouveia R, Martins IP (2018) Clinical description of attack-related cognitive symptoms in migraine: a systematic review. Cephalalgia 38:1335–1350. https://doi.org/10.1177/0333102417728250CrossRefPubMed

Haywood KL, Mars TS, Potter R, Patel S, Matharu M, Underwood M (2018) Assessing the impact of headaches and the outcomes of treatment: a systematic review of patient-reported outcome measures (PROMs). Cephalalgia 38:1374–1386. https://doi.org/10.1177/0333102417731348CrossRefPubMed

Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, Sawyer J (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53:988–994. https://doi.org/10.1212/wnl.53.5.988CrossRefPubMed

10.

Steiner TJ, Jensen R, Katsarava Z, et al (2019) Aids to management of headache disorders in primary care (2nd edition). The Journal of Headache and Pain

11.

NICE (2012) Headaches in over 12s: diagnosis and management. Natl Inst Helath Care Excell 1–30

12.

Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Mandrekar J, on behalf of the International Headache Society Clinical Trials Standing Committee (2019) Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: fourth edition. Cephalalgia 39:687–710. https://doi.org/10.1177/0333102419828967CrossRefPubMedPubMedCentral

13.

McKenzie JA, Cutrer FM (2009) How well do headache patients remember? A comparison of self-report measures of headache frequency and severity in patients with migraine. Headache 49:669–672. https://doi.org/10.1111/j.1526-4610.2009.01411.xCrossRefPubMed

14.

Torelli P, Jensen R (2010) Headache diaries and calendars, 1st ed. Elsevier B.V

15.

(IHS) C of the IHS (2018) Headache classification the international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211. https://doi.org/10.1177/0333102417738202CrossRef

16.

Kosinski M, Bayliss MS, Bjorner JB, Ware Jr JE, Garber WH, Batenhorst A, Cady R, Dahlöf CGH, Dowson A, Tepper S (2003) A six-item short-form survey for measuring headache impact: the HIT-6™. Qual Life Res 12:963–974. https://doi.org/10.1023/A:1026119331193CrossRefPubMed

17.

Westergaard MLS, Steiner TJ, MacGregor EA et al (2013) The Headache Under-Response to Treatment (HURT) questionnaire: assessment of utility in headache specialist care. Cephalalgia 33:245–255. https://doi.org/10.1177/0333102412469740CrossRefPubMed

18.

Ware JE, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233. https://doi.org/10.1097/00005650-199603000-00003CrossRefPubMed

19.

Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4:353–365. https://doi.org/10.2165/00019053-199304050-00006CrossRefPubMed

20.

Spielberger C (1970) STAI manual for the Stait-Trait Anxiety Inventory (“self-evaluation questionnaire”). Consulting Psychologists Press, [Palo Alto Calif]

21.

Ww Z (1965) Zung self-rating depression scale

22.

Abu-Arafeh I, Hershey AD, Diener HC, Tassorelli C (2019) Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition. Cephalalgia 39:803–816. https://doi.org/10.1177/0333102419842188CrossRefPubMed

23.

Tassorelli C, Diener HC, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, for the International Headache Society Clinical Trials Standing Committee (2018) Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults. Cephalalgia 38:815–832. https://doi.org/10.1177/0333102418758283CrossRefPubMed

24.

Tfelt-Hansen P, Pascual J, Ramadan N et al (2012) Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia 32:6–38. https://doi.org/10.1177/0333102411417901CrossRefPubMed

25.

Gallardo V, Trochet J, Torres-Ferrus M, Sanchez del Rio M, Lainez J, Leira R et al. eMIG (I): the impact of digital platforms focused on migraine patient-centered outcome research. In: Migraine Trust International Symposium; London, UK

26.

Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, Wang SJ, for the Task Force of the International Headache Society Clinical Trials Subcommittee (2008) Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 28:484–495. https://doi.org/10.1111/j.1468-2982.2008.01555.xCrossRefPubMed

27.

Serrano D, Lipton RB, Scher AI, Reed ML, Stewart WF, Adams AM, Buse DC (2017) Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design. J Headache Pain 18. https://doi.org/10.1186/s10194-017-0787-1

Title: Headache Gauge: a real-life calendar-based tool for headache monitoring
Authors: Raquel Gil-Gouveia
Inês Brás Marques
Elsa Paixão Parreira
Isabel Pavão Martins
António Gouveia Oliveira
Publication date: 01-10-2021
Publisher: Springer International Publishing
Keywords: Migraine
Tension Headache
Headache
Published in: Neurological Sciences / Issue 10/2021
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05080-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Headache Gauge: a real-life calendar-based tool for headache monitoring

Abstract

Background

Method

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Method

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2021

A wearable tool for continuous monitoring of movement disorders: clinical assessment and comparison with tremor scores

Efficacy of low-level laser therapy in nerve injury repair—a new era in therapeutic agents and regenerative treatments

Acute necrotizing encephalopathy due to SARS-CoV-2 in a pregnant female

Correction to: Shear wave elastography characteristics of upper limb muscle in rigidity-dominant Parkinson’s disease

Unveiling the relationship between autonomic involvement, fatigue, and cognitive dysfunction in early relapsing–remitting multiple sclerosis

ADEM post-Sars-CoV-2 infection in a pediatric patient with Fisher-Evans syndrome